More over at Nature Network Boston:
Last week’s American Heart Association meeting offered a few flare-ups in the debate over how to identify and treat people at risk of heart disease. Two studies raised questions about the usefulness of the C-reactive protein (CRP) blood test championed at Brigham and Women’s Hospital.
So goes the ongoing battle over primary prevention — the use of drugs to prevent disease in healthy people with “risk factors” that make them prone to disease. Some see the approach as a way to stave off illness. Others see primary prevention as a way for drug companies to push marginal medications on healthy people.
For more on the debate over CRP and heart disease see: